Low-dose azithromycin improves phagocytosis of bacteria by both alveolar and monocyte-derived macrophagesin chronic obstructive pulmonary disease subjects

Respirology

Volumn 17, Issue 5, 2012, Pages 802-807

  Hodge, Sandra ^a,b,c   Reynolds, Paul N ^a,b,c  

^a HANSON INSTITUTE   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

alveolar macrophage; azithromycin; chronic obstructive pulmonary disease; monocyte derived macrophage; phagocytosis

Indexed keywords

AZITHROMYCIN; FLUORESCEIN ISOTHIOCYANATE; STEROID;

ADULT; AGED; APOPTOSIS; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; ESCHERICHIA COLI; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LOW DRUG DOSE; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE; MONOCYTE DERIVED MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; STEROID THERAPY; TREATMENT DURATION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; APOPTOSIS; AZITHROMYCIN; BRONCHOALVEOLAR LAVAGE; BRONCHOSCOPY; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI; FEMALE; FLUORESCEIN; HUMANS; LONGITUDINAL STUDIES; MACROPHAGES; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; NECROSIS; PHAGOCYTOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TREATMENT OUTCOME;

EID: 84862988418     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2012.02135.x     Document Type: Article

References (14)

1. Hodge S, Hodge G, Scicchitano R, et al,. Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunol. Cell Biol. 2003; 81: 289-96. (Pubitemid 36904336)
2. Hodge S, Hodge G, Ahern J, et al,. Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease. Am. J. Respir. Cell Mol. Biol. 2007; 37: 748-55. (Pubitemid 350211645)
3. Hodge S, Hodge G, Brozyna S, et al,. Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages. Eur. Respir. J. 2006; 28: 486-95. (Pubitemid 44794662)
4. Hodge S, Hodge G, Holmes M, et al,. Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation. Eur. Respir. J. 2005; 25: 447-54. (Pubitemid 40331174)
5. Wilkinson TMA, Patel IS, Wilks M, et al,. Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2003; 167: 1090-5. (Pubitemid 36459654)
6. Berenson CS, Garlipp MA, Grove LJ, et al,. Impaired phagocytosis of nontypeable Haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary disease. J. Infect. Dis. 2006; 194: 1375-84. (Pubitemid 44706505)
7. Prieto A, Reyes E, Bernstein ED, et al,. Defective natural killer and phagocytic activities in chronic obstructive pulmonary disease are restored by glycophosphopeptical (inmunoferõn). Am. J. Respir. Crit. Care Med. 2001; 163: 1578-83. (Pubitemid 32578759)
8. Taylor AE, Finney-Hayward TK, Quint JK, et al,. Defective macrophage phagocytosis of bacteria in COPD. Eur. Respir. J. 2010; 35: 1039-47.
9. Hodge S, Hodge G, Jersmann H, et al,. Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2008; 178: 139-48. (Pubitemid 351957772)
10. Seemungal TA, Wilkinson TM, Hurst JR, et al,. Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations. Am. J. Respir. Crit. Care Med. 2008; 178: 1139-47.
11. Hodge S, Matthews G, Dean MM, et al,. Therapeutic role for mannose binding lectin in cigarette smoke-induced lung inflammation? Evidence from a murine model. Am. J. Respir. Cell Mol. Biol. 2010; 42: 235-42.
12. Patel KB, Xuan D, Tessier PR, et al,. Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin. Antimicrob. Agents Chemother. 1996; 40: 2375-9. (Pubitemid 26328049)
13. Rodvold KA, Gotfried MH, Danziger LH, et al,. Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers. Antimicrob. Agents Chemother. 1997; 41: 1399-402. (Pubitemid 27231452)
14. Hand WL, Boozer RM, King-Thompson NL,. Antibiotic uptake by alveolar macrophages of smokers. Antimicrob. Agents Chemother. 1985; 27: 42-5. (Pubitemid 15198152)